2025

Barrett, A. et al. (2025) Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: a British Society for Haematology Good Practice Paper. British Journal of Haematology, 206(1), pp. 74-85. (doi: 10.1111/bjh.19840) (PMID:39506502)

2024

Wilson, M. R. , Cwynarski, K., Eyre, T. A., Smith, J., Chaganti, S., Fox, C. P. and McKay, P. (2024) Central nervous system prophylaxis in large B‐cell lymphoma: A British Society for Haematology Good Practice Paper. British Journal of Haematology, 205(6), pp. 2198-2205. (doi: 10.1111/bjh.19686) (PMID:39128894)

Henderson, R. and Wilson, M. (2024) Lymphoma for the acute physician: diagnostic challenges and initial treatment decisions. British Journal of Hospital Medicine, 85(6), pp. 1-9. (doi: 10.12968/hmed.2024.0053) (PMID:38941979)

O'Reilly, M. A. et al. (2024) Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysis. HemaSphere, 8(6), e87. (doi: 10.1002/hem3.87) (PMID:38873532)

Wilson, M. R. et al. (2024) Dosage of high‐dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse. American Journal of Hematology, 99(2), E46-E50. (doi: 10.1002/ajh.27167) (PMID:38037530)

2023

Bobillo, S., Wilson, M. R. and Cwynarski, K. (2023) Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma. Current Opinion in Oncology, 35(5), pp. 382-388. (doi: 10.1097/cco.0000000000000973) (PMID:37551947)

Wilson, M. R. et al. (2023) ‘ACOPP’ chemotherapy for older and less fit patients with Hodgkin lymphoma—a multicentre, retrospective study. British Journal of Haematology, 202(4), pp. 796-800. (doi: 10.1111/bjh.18947) (PMID:37357380)

Wilson, M. R. , Barrett, A., Yoon Cheah, C. and Eyre, T. A. (2023) How I manage mantle cell lymphoma: indolent versus aggressive disease. British Journal of Haematology, 201(2), pp. 185-198. (doi: 10.1111/bjh.18697) (PMID:36807902)

2022

Wilson, M. R. , Bobillo, S. and Cwynarski, K. (2022) CNS prophylaxis in aggressive B-cell lymphoma. Hematology, 2022(1), pp. 138-145. (doi: 10.1182/hematology.2022000331) (PMID:36485105) (PMCID:PMC9820554)

Eyre, T. o. A. et al. (2022) CNS prophylaxis for diffuse large B-cell lymphoma. Lancet Oncology, 23(9), e416-e426. (doi: 10.1016/s1470-2045(22)00371-0) (PMID:36055310)

Wilson, M. R. et al. (2022) Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients. Blood, 139(16), pp. 2499-2511. (doi: 10.1182/blood.2021014506) (PMID:34995350)

2021

Roeker, L. E. et al. (2021) COVID-19 in patients with CLL: improved survival outcomes and update on management strategies. Blood, 138(18), pp. 1768-1773. (doi: 10.1182/blood.2021011841) (PMID:34297826) (PMCID:PMC8313815)

Martinez-Calle, N., Wilson, M. R. , Eyre, T. A., Cwynarski, K., McKay, P. and Fox, C. P. (2021) Interpretation of retrospective data evaluating high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma; caution required. American Journal of Hematology, 96(9), E338-E339. (doi: 10.1002/ajh.26257) (PMID:34050962)

Frontzek, F. et al. (2021) Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma. Nature Communications, 12, 5183. (doi: 10.1038/s41467-021-25405-w) (PMID:34465776) (PMCID:PMC8408158)

Rampotas, A. et al. (2021) Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: a UK and Ireland analysis. British Journal of Haematology, 194(2), pp. 365-377. (doi: 10.1111/bjh.17513) (PMID:33959947)

Horne, G. A. , Laird, J., Latif, A.-L., Irvine, D., Wilson, M. and Douglas, K. (2021) The implications of CAR-T cell therapy on apheresis services: a Scottish perspective. Journal of Clinical Apheresis, 36(3), pp. 513-515. (doi: 10.1002/jca.21871) (PMID:33378123)

McCulloch, R. et al. (2021) Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real‐world analysis of outcomes in 211 patients. British Journal of Haematology, 193(2), pp. 290-298. (doi: 10.1111/bjh.17363) (PMID:33620106)

Oun, H., Wilson, M. , Leach, M. and McKay, P. (2021) Central nervous system relapse of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T‐cell lymphoma. British Journal of Haematology, 193(1), p. 9. (doi: 10.1111/bjh.17267) (PMID:33336793)

Wilson, M. R. , Gordon, W., Goodlad, J., Leach, M. and Bain, B. J. (2021) Erdheim‐Chester disease in bone marrow. American Journal of Hematology, 96(2), pp. 270-271. (doi: 10.1002/ajh.25948) (PMID:33398894)

2020

Mato, A. R. et al. (2020) Outcomes of COVID-19 in patients with CLL: a multicenter international experience. Blood, 136(10), pp. 1134-1143. (doi: 10.1182/blood.2020006965) (PMID:32688395) (PMCID:PMC7472711)

McKay, P., Wilson, M. R. , Chaganti, S., Smith, J., Fox, C. P. and Cwynarski, K. (2020) The prevention of central nervous system relapse in diffuse large B‐cell lymphoma: a British Society for Haematology good practice paper. British Journal of Haematology, 190(5), pp. 708-714. (doi: 10.1111/bjh.16866) (PMID:32433789)

Wilson, M. R. et al. (2020) Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery. Blood Advances, 4(15), pp. 3586-3593. (doi: 10.1182/bloodadvances.2020002421) (PMID:32761231) (PMCID:PMC7422120)

2019

Wilson, M. R. , McKay, P. and Leach, M. (2019) Primary leptomeningeal B‐cell lymphoma. British Journal of Haematology, 187(4), p. 412. (doi: 10.1111/bjh.16163) (PMID:31423572)

Wilson, M. R. , Bagguley, T., Smith, A., Roman, E., Patmore, R., Hanlon, K., Leach, M., Burton, C. and McKay, P. (2019) Frontline management of nodular lymphocyte predominant Hodgkin lymphoma – a retrospective UK multicentre study. British Journal of Haematology, 186(6), e214-e217. (doi: 10.1111/bjh.16109) (PMID:31344253)

Hanlon, K., Wilson, M. R. , Kay, D., Jackson, B. and Leach, M. (2019) Safety and diagnostic yield of splenic core biopsy; a methodical approach using combined haematology/radiology assessment in a tertiary referral centre. British Journal of Haematology, 186(2), p. 371373. (doi: 10.1111/bjh.15867) (PMID:30873597)

2017

Mitchell, L. V., Wilson, M. R. and Holmes, S. (2017) A historic disease still prevalent today. British Medical Journal, 356, j1013. (doi: 10.1136/bmj.j1013) (PMID:28302629)

2016

Wilson, M. R. , Parakramawansha, R., Quinn, T. J. and Tait, R. C. (2016) Quality and predictors of anticoagulant control with vitamin K antagonist for stroke prevention in atrial fibrillation. Thrombosis and Haemostasis, 116(3), pp. 578-580. (doi: 10.1160/TH16-01-0025) (PMID:27307147)

Wilson, M. R. , Docherty, K. F. and Gardner, R. S. (2016) Use of direct oral anticoagulants in thromboembolic disease. Prescriber, 27(8), pp. 15-22. (doi: 10.1002/psb.1487)

2014

Wilson, M. R. , Milne, G. and Vryonis, E. (2014) Kikuchi-fujimoto disease: a rare cause of Fever in the returning traveller. Case Reports in Medicine, 2014, 868190. (doi: 10.1155/2014/868190) (PMID:25574174) (PMCID:PMC4276685)

Wilson, M. R. and Tait, R. C. (2014) Hemostasis and anticoagulants. In: Padmanabhan, S. (ed.) Handbook of Pharmacogenomics and Stratified Medicine. Academic Press: London, pp. 479-496. ISBN 9780123868831 (doi: 10.1016/b978-0-12-386882-4.00023-2)

Articles

Barrett, A. et al. (2025) Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: a British Society for Haematology Good Practice Paper. British Journal of Haematology, 206(1), pp. 74-85. (doi: 10.1111/bjh.19840) (PMID:39506502)

Wilson, M. R. , Cwynarski, K., Eyre, T. A., Smith, J., Chaganti, S., Fox, C. P. and McKay, P. (2024) Central nervous system prophylaxis in large B‐cell lymphoma: A British Society for Haematology Good Practice Paper. British Journal of Haematology, 205(6), pp. 2198-2205. (doi: 10.1111/bjh.19686) (PMID:39128894)

Henderson, R. and Wilson, M. (2024) Lymphoma for the acute physician: diagnostic challenges and initial treatment decisions. British Journal of Hospital Medicine, 85(6), pp. 1-9. (doi: 10.12968/hmed.2024.0053) (PMID:38941979)

O'Reilly, M. A. et al. (2024) Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysis. HemaSphere, 8(6), e87. (doi: 10.1002/hem3.87) (PMID:38873532)

Wilson, M. R. et al. (2024) Dosage of high‐dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse. American Journal of Hematology, 99(2), E46-E50. (doi: 10.1002/ajh.27167) (PMID:38037530)

Bobillo, S., Wilson, M. R. and Cwynarski, K. (2023) Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma. Current Opinion in Oncology, 35(5), pp. 382-388. (doi: 10.1097/cco.0000000000000973) (PMID:37551947)

Wilson, M. R. et al. (2023) ‘ACOPP’ chemotherapy for older and less fit patients with Hodgkin lymphoma—a multicentre, retrospective study. British Journal of Haematology, 202(4), pp. 796-800. (doi: 10.1111/bjh.18947) (PMID:37357380)

Wilson, M. R. , Barrett, A., Yoon Cheah, C. and Eyre, T. A. (2023) How I manage mantle cell lymphoma: indolent versus aggressive disease. British Journal of Haematology, 201(2), pp. 185-198. (doi: 10.1111/bjh.18697) (PMID:36807902)

Wilson, M. R. , Bobillo, S. and Cwynarski, K. (2022) CNS prophylaxis in aggressive B-cell lymphoma. Hematology, 2022(1), pp. 138-145. (doi: 10.1182/hematology.2022000331) (PMID:36485105) (PMCID:PMC9820554)

Eyre, T. o. A. et al. (2022) CNS prophylaxis for diffuse large B-cell lymphoma. Lancet Oncology, 23(9), e416-e426. (doi: 10.1016/s1470-2045(22)00371-0) (PMID:36055310)

Wilson, M. R. et al. (2022) Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients. Blood, 139(16), pp. 2499-2511. (doi: 10.1182/blood.2021014506) (PMID:34995350)

Roeker, L. E. et al. (2021) COVID-19 in patients with CLL: improved survival outcomes and update on management strategies. Blood, 138(18), pp. 1768-1773. (doi: 10.1182/blood.2021011841) (PMID:34297826) (PMCID:PMC8313815)

Martinez-Calle, N., Wilson, M. R. , Eyre, T. A., Cwynarski, K., McKay, P. and Fox, C. P. (2021) Interpretation of retrospective data evaluating high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma; caution required. American Journal of Hematology, 96(9), E338-E339. (doi: 10.1002/ajh.26257) (PMID:34050962)

Frontzek, F. et al. (2021) Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma. Nature Communications, 12, 5183. (doi: 10.1038/s41467-021-25405-w) (PMID:34465776) (PMCID:PMC8408158)

Rampotas, A. et al. (2021) Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: a UK and Ireland analysis. British Journal of Haematology, 194(2), pp. 365-377. (doi: 10.1111/bjh.17513) (PMID:33959947)

Horne, G. A. , Laird, J., Latif, A.-L., Irvine, D., Wilson, M. and Douglas, K. (2021) The implications of CAR-T cell therapy on apheresis services: a Scottish perspective. Journal of Clinical Apheresis, 36(3), pp. 513-515. (doi: 10.1002/jca.21871) (PMID:33378123)

McCulloch, R. et al. (2021) Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real‐world analysis of outcomes in 211 patients. British Journal of Haematology, 193(2), pp. 290-298. (doi: 10.1111/bjh.17363) (PMID:33620106)

Oun, H., Wilson, M. , Leach, M. and McKay, P. (2021) Central nervous system relapse of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T‐cell lymphoma. British Journal of Haematology, 193(1), p. 9. (doi: 10.1111/bjh.17267) (PMID:33336793)

Wilson, M. R. , Gordon, W., Goodlad, J., Leach, M. and Bain, B. J. (2021) Erdheim‐Chester disease in bone marrow. American Journal of Hematology, 96(2), pp. 270-271. (doi: 10.1002/ajh.25948) (PMID:33398894)

Mato, A. R. et al. (2020) Outcomes of COVID-19 in patients with CLL: a multicenter international experience. Blood, 136(10), pp. 1134-1143. (doi: 10.1182/blood.2020006965) (PMID:32688395) (PMCID:PMC7472711)

McKay, P., Wilson, M. R. , Chaganti, S., Smith, J., Fox, C. P. and Cwynarski, K. (2020) The prevention of central nervous system relapse in diffuse large B‐cell lymphoma: a British Society for Haematology good practice paper. British Journal of Haematology, 190(5), pp. 708-714. (doi: 10.1111/bjh.16866) (PMID:32433789)

Wilson, M. R. et al. (2020) Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery. Blood Advances, 4(15), pp. 3586-3593. (doi: 10.1182/bloodadvances.2020002421) (PMID:32761231) (PMCID:PMC7422120)

Wilson, M. R. , McKay, P. and Leach, M. (2019) Primary leptomeningeal B‐cell lymphoma. British Journal of Haematology, 187(4), p. 412. (doi: 10.1111/bjh.16163) (PMID:31423572)

Wilson, M. R. , Bagguley, T., Smith, A., Roman, E., Patmore, R., Hanlon, K., Leach, M., Burton, C. and McKay, P. (2019) Frontline management of nodular lymphocyte predominant Hodgkin lymphoma – a retrospective UK multicentre study. British Journal of Haematology, 186(6), e214-e217. (doi: 10.1111/bjh.16109) (PMID:31344253)

Hanlon, K., Wilson, M. R. , Kay, D., Jackson, B. and Leach, M. (2019) Safety and diagnostic yield of splenic core biopsy; a methodical approach using combined haematology/radiology assessment in a tertiary referral centre. British Journal of Haematology, 186(2), p. 371373. (doi: 10.1111/bjh.15867) (PMID:30873597)

Mitchell, L. V., Wilson, M. R. and Holmes, S. (2017) A historic disease still prevalent today. British Medical Journal, 356, j1013. (doi: 10.1136/bmj.j1013) (PMID:28302629)

Wilson, M. R. , Parakramawansha, R., Quinn, T. J. and Tait, R. C. (2016) Quality and predictors of anticoagulant control with vitamin K antagonist for stroke prevention in atrial fibrillation. Thrombosis and Haemostasis, 116(3), pp. 578-580. (doi: 10.1160/TH16-01-0025) (PMID:27307147)

Wilson, M. R. , Docherty, K. F. and Gardner, R. S. (2016) Use of direct oral anticoagulants in thromboembolic disease. Prescriber, 27(8), pp. 15-22. (doi: 10.1002/psb.1487)

Wilson, M. R. , Milne, G. and Vryonis, E. (2014) Kikuchi-fujimoto disease: a rare cause of Fever in the returning traveller. Case Reports in Medicine, 2014, 868190. (doi: 10.1155/2014/868190) (PMID:25574174) (PMCID:PMC4276685)

Book Sections

Wilson, M. R. and Tait, R. C. (2014) Hemostasis and anticoagulants. In: Padmanabhan, S. (ed.) Handbook of Pharmacogenomics and Stratified Medicine. Academic Press: London, pp. 479-496. ISBN 9780123868831 (doi: 10.1016/b978-0-12-386882-4.00023-2)